158 related articles for article (PubMed ID: 28367635)
1. A Single-Center Long-Term Continuous Subcutaneous Insulin Infusion (CSII) Experience: Higher Fractional Use Is Associated With Less Diabetes Complications.
Tubili C; Folco UD; Nardone MR; Clementi A
J Diabetes Sci Technol; 2017 Sep; 11(5):1057-1058. PubMed ID: 28367635
[No Abstract] [Full Text] [Related]
2. Continuous subcutaneous insulin infusion (CSII) pumps.
Valla V
Adv Exp Med Biol; 2012; 771():414-9. PubMed ID: 23393693
[TBL] [Abstract][Full Text] [Related]
3. Type 1 diabetes control and pregnancy outcomes in women treated with continuous subcutaneous insulin infusion (CSII) or with insulin glargine and multiple daily injections of rapid-acting insulin analogues (glargine-MDI).
Bruttomesso D; Bonomo M; Costa S; Dal Pos M; Di Cianni G; Pellicano F; Vitacolonna E; Dodesini AR; Tonutti L; Lapolla A; Di Benedetto A; Torlone E;
Diabetes Metab; 2011 Nov; 37(5):426-31. PubMed ID: 21474360
[TBL] [Abstract][Full Text] [Related]
4. Diabetic Ketoacidosis Among Patients Treated With Continuous Subcutaneous Insulin Infusion.
Dogan ADA; Jørgensen UL; Gjessing HJ
J Diabetes Sci Technol; 2017 May; 11(3):631-632. PubMed ID: 27595713
[No Abstract] [Full Text] [Related]
5. Frequency of dermatological side effects of continuous subcutaneous insulin infusion in children and adolescents with type 1 diabetes.
Binder E; Lange O; Edlinger M; Meraner D; Abt D; Moser C; Steichen E; Hofer SE
Exp Clin Endocrinol Diabetes; 2015 Apr; 123(4):260-4. PubMed ID: 25607337
[TBL] [Abstract][Full Text] [Related]
6. [The use of continuous subcutaneous insulin infusion (CSII) with personal insulin pumps in the treatment of children and adolescents with diabetes type 1].
Jarosz-Chobot P
Wiad Lek; 2004; 57(5-6):263-6. PubMed ID: 15518073
[TBL] [Abstract][Full Text] [Related]
7. Insulin pumps in hospital: a guide for the generalist physician.
Evans K
Clin Med (Lond); 2013 Jun; 13(3):244-7. PubMed ID: 23760696
[TBL] [Abstract][Full Text] [Related]
8. Continuous subcutaneous insulin infusion therapy: A primer on insulin pumps.
Potti LG; Haines ST
J Am Pharm Assoc (2003); 2009; 49(1):e1-13; quiz e14-7. PubMed ID: 19196588
[TBL] [Abstract][Full Text] [Related]
9. The importance of anti-insulin antibody in patients with type 1 diabetes mellitus treated with continuous subcutaneous insulin infusion or multiple daily insulin injections therapy.
Sahin SB; Cetinkalp S; Ozgen AG; Saygili F; Yilmaz C
Acta Diabetol; 2010 Dec; 47(4):325-30. PubMed ID: 20842389
[TBL] [Abstract][Full Text] [Related]
10. Effect of infusion rate and indwelling time on tissue resistance pressure in small-volume subcutaneous infusion like in continuous subcutaneous insulin infusion.
Patte C; Pleus S; Wiegel C; Schiltges G; Jendrike N; Haug C; Freckmann G
Diabetes Technol Ther; 2013 Apr; 15(4):289-94. PubMed ID: 23427865
[TBL] [Abstract][Full Text] [Related]
11. Nonmetabolic complications of continuous subcutaneous insulin infusion: a patient survey.
Pickup JC; Yemane N; Brackenridge A; Pender S
Diabetes Technol Ther; 2014 Mar; 16(3):145-9. PubMed ID: 24180294
[TBL] [Abstract][Full Text] [Related]
12. Comparison of Insulin Pump Therapy and Multiple Daily Injections Insulin Regimen in Patients with Type 1 Diabetes During Ramadan Fasting.
Alamoudi R; Alsubaiee M; Alqarni A; Saleh Y; Aljaser S; Salam A; Eledrisi M
Diabetes Technol Ther; 2017 Jun; 19(6):349-354. PubMed ID: 28296467
[TBL] [Abstract][Full Text] [Related]
13. Long-term health economic benefits of sensor-augmented pump therapy vs continuous subcutaneous insulin infusion alone in type 1 diabetes: a U.K. perspective.
Roze S; Smith-Palmer J; Valentine WJ; Cook M; Jethwa M; de Portu S; Pickup JC
J Med Econ; 2016; 19(3):236-42. PubMed ID: 26510389
[TBL] [Abstract][Full Text] [Related]
14. Role of Devices in Insulin Delivery.
Meneghini LF; McNulty JN
Diabetes Technol Ther; 2017 Feb; 19(2):76-78. PubMed ID: 28118052
[No Abstract] [Full Text] [Related]
15. [Current status of continuous subcutaneous insulin infusion and continuous glucose monitoring systems in the Community of Madrid].
Arranz Martín A; Calle Pascual A; Del Cañizo Gómez FJ; González Albarrán O; Lisbona Gil A; Botella Serrano M; Pallardo Sánchez LF;
Endocrinol Nutr; 2015 Apr; 62(4):171-9. PubMed ID: 25726367
[TBL] [Abstract][Full Text] [Related]
16. [Continuous subcutaneous insulin infusion].
Ito H; Kanatsuka A
Nihon Rinsho; 1997 Nov; 55 Suppl():267-72. PubMed ID: 9434479
[No Abstract] [Full Text] [Related]
17. Continuous subcutaneous insulin infusion: Special needs for children.
Adolfsson P; Ziegler R; Hanas R
Pediatr Diabetes; 2017 Jun; 18(4):255-261. PubMed ID: 28425167
[TBL] [Abstract][Full Text] [Related]
18. Severe insulin allergy successfully treated with continuous subcutaneous insulin infusion.
Fujikawa T; Imbe H; Date M; Go Y; Kitaoka H
Diabetes Res Clin Pract; 2012 Aug; 97(2):e31-3. PubMed ID: 22609054
[TBL] [Abstract][Full Text] [Related]
19. Dermatological complications of continuous subcutaneous insulin infusion in children and adolescents.
Conwell LS; Pope E; Artiles AM; Mohanta A; Daneman A; Daneman D
J Pediatr; 2008 May; 152(5):622-8. PubMed ID: 18410763
[TBL] [Abstract][Full Text] [Related]
20. Treatment of mild-to-moderate hypoglycemia in patients with type 1 diabetes treated with insulin pump therapy: are current recommendations effective?
Gingras V; Desjardins K; Smaoui MR; Savard V; Messier V; Haidar A; Legault L; Rabasa-Lhoret R
Acta Diabetol; 2018 Mar; 55(3):227-231. PubMed ID: 29224132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
